Utility of a buccal swab point-of-care test for the ifnl4 genotype in the era of direct acting antivirals for hepatitis c virus

HIGHLIGHTS

• who: Aminata Sy et al. from the Institute of Medical Research, NIGERIA , MRC Clinical Trials Unit, University College London, London, United Kingdom, Peter Medawar Building have published the research: Utility of a buccal swab point-of-care test for the IFNL4 genotype in the era of direct acting antivirals for hepatitis C virus, in the Journal: PLOS ONE of January/23,/2023
• what: The aim of this substudy was to compare the performance of both platforms with respect to IFNL4 status.
• how: The study was conducted in accordance with the International Conference on . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.